ATI RN
RN VATI Pharmacology S 2019 Questions
Extract:
Question 1 of 5
A nurse in the emergency department is planning care for a client who had a myocardial infarction and is receiving thrombolytic therapy with an WV infusion of alteplase. Which of the following interventions should the nurse include in the plan?
Correct Answer: D
Rationale: Monitoring for changes in level of consciousness is critical during alteplase therapy to detect intracranial bleeding, a serious complication.
Question 2 of 5
A nurse discovers that a client has been administered a higher dose of oxybutynin than the prescription indicates. The nurse should assess the client for which of the following adverse effects?
Correct Answer: D
Rationale: Oxybutynin, an anticholinergic, can cause bradycardia due to inhibition of acetylcholine, which regulates heart rate. Assessing for bradycardia is critical after an overdose.
Question 3 of 5
A nurse is caring for a client who has a new prescription for metformin. Which of the following laboratory results should the nurse evaluate prior to administering the first dose?
Correct Answer: B
Rationale: Before administering the first dose of metformin, the nurse should evaluate the client's creatinine level. Metformin is primarily excreted by the kidneys, and its clearance depends on renal function. Elevated creatinine levels indicate impaired kidney function, which can lead to metformin accumulation and increase the risk of lactic acidosis.
Question 4 of 5
A nurse is providing teaching for a client who has a prescription for gentamicin. Which of the following should the nurse include as an adverse effect of this medication?
Correct Answer: D
Rationale: Gentamicin can cause ototoxicity, leading to tinnitus, a symptom of inner ear damage. Clients should report this immediately to prevent further complications.
Question 5 of 5
A nurse is caring for a client who is receiving neostigmine. Which of the following manifestations should the nurse identify as an adverse reaction to the medication?
Correct Answer: B,C,E
Rationale: Neostigmine's cholinergic effects can cause sweating, respiratory distress (due to bronchoconstriction), and bradycardia (via vagal stimulation).